Sources
Source catalog
A public catalog of papers, trials, laws, policy records, podcasts, documentaries, books, cultural sources, claim records, and reference pages.
Sources indexed346
Browse the catalog
Search every indexed source or filter by type. Each result links to the original — the catalog is a finding aid, so open the source before relying on a claim.
Source types
Journalism155
Podcast Interview64
State Policy Coverage Row51
Policy Tracker Row17
Peer Reviewed Study14
Clinical Trial Registry9
Condition Evidence Template8
State Policy3
Clinic Observatory Schema2
Company Release2
Confidence labels
Primary-source record181
Media metadata64
State policy coverage row51
Peer-reviewed paper11
Registry record9
Evidence framework7
Peer-reviewed source6
Case report3
Claim record3
Cultural Stewardship2
Wanted sources
These are the gaps that would most improve the public reference.
- Named medical reviewers: Cardiology, addiction medicine, emergency medicine, pharmacology, and psychiatry reviewers who are willing to be listed.
- Named cultural advisors: Gabonese, Bwiti/Bwete-linked, conservation, and stewardship advisors only when they consent to public naming.
- Adverse-event case material: Peer-reviewed case reports, agency records, and serious journalism with enough detail to separate signal from speculation.
- State-policy primary records: Bill text, fiscal notes, committee reports, hearing video, agency pages, and final signed law when available.
- Primary media links: Original podcast, YouTube, documentary, book, and interview pages rather than reposted summaries.
Catalog preview
Source type: StudyConfidence: High
Magnesium-ibogaine therapy in veterans with traumatic brain injuries
Prospective open-label observational study of 30 male special-operations veterans who independently received magnesium-ibogaine treatment at Ambio Life Sciences in Mexico, with Stanford assessments before and after. The paper reports large short-term improvements and no unexpected serious adverse events, while stating that controlled clinical trials are needed.
Source type: StudyConfidence: High
Magnesium-ibogaine therapy effects on cortical oscillations and neural complexity in veterans with traumatic brain injury
Follow-up Nature Mental Health article on EEG and neural-complexity measures in the same broad magnesium-ibogaine veteran TBI research lane. It reports neurophysiological changes after treatment and states that controlled trials are needed to confirm findings.
Source type: StudyConfidence: Low
Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis
Two-patient case report involving Ambio-affiliated authors and Ambio treatment records. Treat as preliminary case-report evidence with prominent conflict-of-interest and funder-involvement labels, not proof of efficacy.
Source type: StudyConfidence: Low
Ibogaine for the treatment of Parkinson's disease: a case report
Track as exciting but very preliminary. One patient, low-dose course, validated PD instruments, no adverse events recorded, sleep worsened; not efficacy proof.
Source type: StudyConfidence: High
Accelerated recovery using magnesium ibogaine: subjective experience analysis
Qualitative analysis from the 30-person MISTIC veteran cohort; interpret alongside open-label design limits.
Source type: StudyConfidence: High
Mystical experiences during magnesium-Ibogaine associated with PTSD symptom improvements in veterans
Track as 30-male-veteran secondary analysis from MISTIC; association does not prove mechanism or general efficacy.
Source type: StudyConfidence: High
Magnesium-ibogaine therapy effects on cortical oscillations and neural complexity
Track as follow-on analysis from the veteran TBI research line.
Source type: StudyConfidence: High
Efficient and modular synthesis of ibogaine and related alkaloids
Important for supply, analog research, and non-plant-derived chemistry coverage.
Source type: StudyConfidence: Moderate
A study of oral ibogaine in opioid withdrawal
Track recruitment/status, sponsor, eligibility criteria, and posted results.
Source type: StudyConfidence: High
Veterans Say an Illegal Psychedelic Drug Is Helping Them. Now Mississippi Wants to Study Ibogaine. - Mississippi Free Press
Research source from Mississippi Free Press. Study design, sample size, limitations, and safety signals matter.
Source type: CultureConfidence: High
Ibogaine’s Surge in Popularity Could Be a Huge Loss for the Gabonese People Unless We Shift Course - psychedelicalpha.com
Culture or stewardship source from psychedelicalpha.com. Outsider summaries require humility and source awareness.
Source type: StudyConfidence: Moderate
Ibogaine and 5-MeO-DMT for addiction treatment with Garyth Moxey
Research source from Psychedelic Therapy Frontiers. Study design, sample size, limitations, and safety signals matter.
Source type: StudyConfidence: High
Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis - Frontiers
Research source from Frontiers. Study design, sample size, limitations, and safety signals matter.
Source type: StudyConfidence: High
Induction of insulin secretion by an aqueous extract of Tabernanhte iboga Baill. (Apocynaceae) in rat pancreatic islets of Langerhans - ScienceDirect
Research source from ScienceDirect. Study design, sample size, limitations, and safety signals matter.
Source type: StudyConfidence: High
Study Identifies Compounds Similar to Ibogaine That May Improve Treatment of Opioid Addiction - Association of American Universities (AAU)
Research source from Association of American Universities (AAU). Study design, sample size, limitations, and safety signals matter.
Source type: StudyConfidence: High
Rare but relevant: Ibogaine and cardiovascular complications—prolonged QT interval and ventricular arrhythmias - Wiley Online Library
Research source from Wiley Online Library. Study design, sample size, limitations, and safety signals matter.
Source type: LawConfidence: High
A Texas hallucinogen hub? $100 million for ibogaine testing brings leading firm to Austin - MSN
Law or policy source from MSN. Read the exact source before drawing legal conclusions.
Source type: StudyConfidence: High
Ibogaine Detoxification Transitions Opioid and Cocaine Abusers Between Dependence and Abstinence: Clinical Observations and Treatment Outcomes - Frontiers
Research source from Frontiers. Study design, sample size, limitations, and safety signals matter.
Source type: LawConfidence: High
Bush: Ibogaine saved my family - A Mississippi veteran’s perspective - RedHillsMSNews.com
Law or policy source from RedHillsMSNews.com. Read the exact source before drawing legal conclusions.
Source type: StudyConfidence: High
Response to Luz & Mash on cardiac toxicity of ibogaine - Schellekens - 2022 - Addiction - Wiley Online Library
Research source from Wiley Online Library. Study design, sample size, limitations, and safety signals matter.
Source type: StudyConfidence: High
Ohio lawmakers consider joining other states to test psychedelic-assisted treatments - Ohio Capital Journal
Research source from Ohio Capital Journal. Study design, sample size, limitations, and safety signals matter.
Source type: StudyConfidence: High
Texas to launch independent psychedelic study after drug companies miss mark - FOX 7 Austin
Research source from FOX 7 Austin. Study design, sample size, limitations, and safety signals matter.
Source type: StudyConfidence: High
Legislative updates in Mississippi, West Virginia, Oregon, and New Hampshire; Fast-tracked federal approval of Compass's synthetic psilocybin was vetoed; Federal bill proposes VA study psychedelics - The Microdose | Substack
Research source from The Microdose | Substack. Study design, sample size, limitations, and safety signals matter.
Source type: StudyConfidence: High
Protective effect of the aqueous extract of Tabernaemontana stapfiana (Apocynaceae) stem bark against monosodium glutamate-induced neurotoxicity in Swiss albino mice.
Research source from IBRO neuroscience reports. Study design, sample size, limitations, and safety signals matter.
Source type: StudyConfidence: High
Rare but relevant: Ibogaine and cardiovascular complications-prolonged QT interval and ventricular arrhythmias.
Research source from Addiction (Abingdon, England). Study design, sample size, limitations, and safety signals matter.
Source type: StudyConfidence: High
Exploring the Use of Ibogaine in Opioid Recovery: Insights from Lived Experience.
Research source from Journal of psychoactive drugs. Study design, sample size, limitations, and safety signals matter.
Source type: StudyConfidence: Moderate
Ibogaine in the Treatment of Alcoholism: an Open-label Escalating-dose Trial
COMPLETED
Source type: StudyConfidence: High
From monotherapy to sequential models: An updated scoping review on ibogaine's role in treatment for psychiatric disorders.
Research source from Journal of psychopharmacology (Oxford, England). Study design, sample size, limitations, and safety signals matter.
Source type: StudyConfidence: High
Development of Bioisosteres of Iboga Alkaloids: A Step-Economical Synthesis to Enhance the Antinociceptive and Anxiolytic Activity with Neuroprotective Effects.
Research source from ACS pharmacology & translational science. Study design, sample size, limitations, and safety signals matter.
Source type: StudyConfidence: High
Blinding Integrity in Psychedelic Randomized Clinical Trials: A Systematic Review.
Research source from JAMA psychiatry. Study design, sample size, limitations, and safety signals matter.
Source type: StudyConfidence: High
Oral 18-methoxycoronaridine activity in simian and murine Leishmania amazonensis infection.
Research source from Frontiers in pharmacology. Study design, sample size, limitations, and safety signals matter.
Source type: StudyConfidence: High
Unlocking the cytotoxic potential of Apocynaceae monoterpene indole and bis-indole alkaloids: a review.
Research source from Natural product research. Study design, sample size, limitations, and safety signals matter.
Source type: StudyConfidence: High
Tabernaemontana catharinensis: A Source of Indole Alkaloids With Potential Activity as Chemotherapeutic Agents.
Research source from Chemistry & biodiversity. Study design, sample size, limitations, and safety signals matter.
Source type: StudyConfidence: High
US speeds up research into mind-altering drugs - including mysterious 'ibogaine'.
Research source from Nature. Study design, sample size, limitations, and safety signals matter.
Source type: MediaConfidence: High
Psychedelic Stocks Rally After Trump’s Executive Order - Forbes
News or commentary from Forbes. Use it to understand public discussion and timing; verify important claims against primary sources.
Source type: StudyConfidence: Moderate
Personality and Drug Use (PDU)
WITHDRAWN
Source type: StudyConfidence: Moderate
Trifecta Research Study
WITHDRAWN
Source type: StudyConfidence: Moderate
Preliminary Efficacy and Safety of Ibogaine in the Treatment of Methadone Detoxification
COMPLETED
Source type: StudyConfidence: Moderate
Pre-post Evaluation of the Safety and Efficacy of Ibogaine-Magnesium Therapy in Veterans With Repeated Blast Exposure
ACTIVE_NOT_RECRUITING
Source type: StudyConfidence: Moderate
Mapping Ibogaine Neural Dynamics in Opioid Use Disorder
RECRUITING
Source type: StudyConfidence: Moderate
Multiple Ascending Dose Noribogaine PK/PD in Healthy Volunteers
COMPLETED
Source type: TrialConfidence: High
FDA allows early-phase noribogaine hydrochloride study for alcohol use disorder to proceed
Important policy and research signal. FDA permission to proceed is not approval, safety proof, or efficacy proof.
Source type: TrialConfidence: Moderate
UTMB Health and UTHealth Houston awarded $50M to lead ibogaine clinical trials
Track consortium members, trial registration, matching funds, and protocol publication.
Source type: TrialConfidence: Moderate
HRA summary for multiple ascending dose noribogaine PK/PD study
NCT06480981; track trial status, design, endpoints, sponsor, and QT/cardiac monitoring language.
Source type: TrialConfidence: High
Texas will launch its own clinical trials into ibogaine psychedelic after failing to find a drug company to help - KSAT
Research or trial-status source from KSAT. A listing or announcement does not prove safety, efficacy, approval, or availability.
Source type: TrialConfidence: High
TN clears way for clinical trials of ibogaine, same drug classification as LSD - WZTV
Research or trial-status source from WZTV. A listing or announcement does not prove safety, efficacy, approval, or availability.
Source type: TrialConfidence: High
Tennessee lawmakers approve HOPE Act to allow ibogaine clinical trials for addiction - WTVC
Research or trial-status source from WTVC. A listing or announcement does not prove safety, efficacy, approval, or availability.
Source type: TrialConfidence: High
What to know about ibogaine as Texas lawmakers eye clinical trial - USA Today
Research or trial-status source from USA Today. A listing or announcement does not prove safety, efficacy, approval, or availability.